264 - Cytopenias, Myelodysplastic Syndromes and Acute Myeloid Leukemia Following Approved Chimeric Antigen Receptor (CAR) T-Cell Therapies: Analysis of the FDA Adverse Event Reporting System (FAERS) Database

Abstract

Open access

Peer reviewed

Lien Qasrawi, Jill Kolesar and Ayman Qasrawi

Transplantation and cellular therapy, Vol.29(2), pp.S204-S204

02/2023

DOI: 10.1016/S2666-6367(23)00333-0

Files and links (1)

url

https://doi.org/10.1016/S2666-6367(23)00333-0View

Published (Version of record) Open Access

Title: Subtitle: 264 - Cytopenias, Myelodysplastic Syndromes and Acute Myeloid Leukemia Following Approved Chimeric Antigen Receptor (CAR) T-Cell Therapies: Analysis of the FDA Adverse Event Reporting System (FAERS) Database
Creators: Lien Qasrawi
Jill Kolesar
Ayman Qasrawi
Resource Type: Abstract
Publication Details: Transplantation and cellular therapy, Vol.29(2), pp.S204-S204
Publisher: Elsevier Inc
DOI: 10.1016/S2666-6367(23)00333-0
ISSN: 2666-6367
eISSN: 2666-6367
Language: English
Date published: 02/2023
Academic Unit: Pharmacy; Pharmaceutical Sciences and Experimental Therapeutics
Record Identifier: 9984695789302771

1 Record Views